| # | Drug | Count |
|---|---|---|
| 0 | FUROSEMIDE | 1010 |
| 1 | SACUBITRIL AND VALSARTAN | 615 |
| 2 | SPIRONOLACTONE | 599 |
| 3 | BISOPROLOL FUMARATE | 521 |
| 4 | ASPIRIN | 382 |
| 5 | ASPIRIN 325 MG | 371 |
| 6 | ASPIRIN 81 MG | 371 |
| 7 | CARVEDILOL | 338 |
| 8 | APIXABAN | 294 |
| 9 | EPLERENONE | 274 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TAFAMIDIS MEGLUMINE | 194 | 0.0401 |
| 1 | EPLERENONE | 274 | 0.0209 |
| 2 | IVABRADINE | 87 | 0.0125 |
| 3 | TOLVAPTAN | 159 | 0.0107 |
| 4 | TAFAMIDIS | 122 | 0.0100 |
| 5 | FEBUXOSTAT TABLETS 40 MG | 64 | 0.0061 |
| 6 | TORSEMIDE | 201 | 0.0059 |
| 7 | SACUBITRIL AND VALSARTAN | 615 | 0.0053 |
| 8 | APIXABAN | 294 | 0.0043 |
| 9 | SPIRONOLACTONE | 599 | 0.0042 |
| # | Drug class | Count |
|---|---|---|
| 0 | Loop Diuretic [EPC] | 1181 |
| 1 | Aldosterone Antagonist [EPC] | 855 |
| 2 | Angiotensin 2 Receptor Blocker [EPC] | 841 |
| 3 | Factor Xa Inhibitor [EPC] | 495 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 477 |
| 5 | beta-Adrenergic Blocker [EPC] | 404 |
| 6 | Platelet Aggregation Inhibitor [EPC] | 386 |
| 7 | HMG-CoA Reductase Inhibitor [EPC] | 375 |
| 8 | Corticosteroid [EPC] | 358 |
| 9 | alpha-Adrenergic Blocker [EPC] | 345 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Lead Chelator [EPC] | 1 | 0.0119 |
| 1 | Interleukin-5 Antagonist [EPC] | 8 | 0.0116 |
| 2 | Vasopressin V2 Receptor Antagonist [EPC] | 159 | 0.0107 |
| 3 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 22 | 0.0097 |
| 4 | Complement C5 Inhibitor [EPC] | 1 | 0.0083 |
| 5 | Aldosterone Antagonist [EPC] | 855 | 0.0055 |
| 6 | Guanylate Cyclase-C Agonist [EPC] | 9 | 0.0043 |
| 7 | Carnitine Analog [EPC] | 14 | 0.0038 |
| 8 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 308 | 0.0028 |
| 9 | CD38-directed Cytolytic Antibody [EPC] | 16 | 0.0027 |